[go: up one dir, main page]

FI20001460A0 - Probiootit atooppisten sairauksien primaariseen ehkäisyyn - Google Patents

Probiootit atooppisten sairauksien primaariseen ehkäisyyn

Info

Publication number
FI20001460A0
FI20001460A0 FI20001460A FI20001460A FI20001460A0 FI 20001460 A0 FI20001460 A0 FI 20001460A0 FI 20001460 A FI20001460 A FI 20001460A FI 20001460 A FI20001460 A FI 20001460A FI 20001460 A0 FI20001460 A0 FI 20001460A0
Authority
FI
Finland
Prior art keywords
atopic diseases
probiotics
primary prophylaxis
prophylaxis
primary
Prior art date
Application number
FI20001460A
Other languages
English (en)
Swedish (sv)
Other versions
FI110668B (fi
FI20001460L (fi
Inventor
Erika Isolauri
Seppo Salminen
Original Assignee
Aboatech Ab Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8558595&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20001460(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aboatech Ab Oy filed Critical Aboatech Ab Oy
Priority to FI20001460A priority Critical patent/FI110668B/fi
Publication of FI20001460A0 publication Critical patent/FI20001460A0/fi
Priority to DE60139554T priority patent/DE60139554D1/de
Priority to ES09164285T priority patent/ES2721848T3/es
Priority to AT01951716T priority patent/ATE439138T1/de
Priority to ES01951716T priority patent/ES2329549T3/es
Priority to EP09164284.3A priority patent/EP2201955B1/en
Priority to AU72572/01A priority patent/AU784921B2/en
Priority to PCT/FI2001/000588 priority patent/WO2001097822A1/en
Priority to US10/311,706 priority patent/US7112322B2/en
Priority to DE01951716T priority patent/DE01951716T1/de
Priority to PT91642843T priority patent/PT2201955T/pt
Priority to ES09164284T priority patent/ES2754797T3/es
Priority to PT01951716T priority patent/PT1296694E/pt
Priority to EP09164285.0A priority patent/EP2206507B1/en
Priority to EP01951716A priority patent/EP1296694B1/en
Publication of FI20001460L publication Critical patent/FI20001460L/fi
Publication of FI110668B publication Critical patent/FI110668B/fi
Application granted granted Critical
Priority to US11/225,204 priority patent/US7988960B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20001460A 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn FI110668B (fi)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP01951716A EP1296694B1 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
PCT/FI2001/000588 WO2001097822A1 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
PT91642843T PT2201955T (pt) 2000-06-20 2001-06-20 Bifidobacterium lactis bb-12 na prevenção primária de doenças atópicas
AT01951716T ATE439138T1 (de) 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen
ES01951716T ES2329549T3 (es) 2000-06-20 2001-06-20 Probioticos para la prevencion primaria de enfermedades atopicas.
EP09164284.3A EP2201955B1 (en) 2000-06-20 2001-06-20 Bifidobacterium lactis Bb-12 in primary prevention of atopic diseases
AU72572/01A AU784921B2 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
DE60139554T DE60139554D1 (de) 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen
US10/311,706 US7112322B2 (en) 2000-06-20 2001-06-20 Probiotics in primary prevention of atopic diseases
DE01951716T DE01951716T1 (de) 2000-06-20 2001-06-20 Probiotika zur primären prävention atopischer erkrankungen
ES09164285T ES2721848T3 (es) 2000-06-20 2001-06-20 Probióticos para su uso en la prevención primaria de enfermedades atópicas
ES09164284T ES2754797T3 (es) 2000-06-20 2001-06-20 Bifidobacterium lactis Bb-12 en prevención primaria de enfermedades atópicas
PT01951716T PT1296694E (pt) 2000-06-20 2001-06-20 Probióticos na prevenção primária de doenças atópicas
EP09164285.0A EP2206507B1 (en) 2000-06-20 2001-06-20 Probiotics for use in primary prevention of atopic diseases
US11/225,204 US7988960B2 (en) 2000-06-20 2005-09-14 Probiotics in primary prevention of atopic diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
FI20001460 2000-06-20

Publications (3)

Publication Number Publication Date
FI20001460A0 true FI20001460A0 (fi) 2000-06-20
FI20001460L FI20001460L (fi) 2001-12-21
FI110668B FI110668B (fi) 2003-03-14

Family

ID=8558595

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn

Country Status (9)

Country Link
US (2) US7112322B2 (fi)
EP (3) EP2201955B1 (fi)
AT (1) ATE439138T1 (fi)
AU (1) AU784921B2 (fi)
DE (2) DE60139554D1 (fi)
ES (3) ES2721848T3 (fi)
FI (1) FI110668B (fi)
PT (2) PT1296694E (fi)
WO (1) WO2001097822A1 (fi)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
JP4212838B2 (ja) 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
RU2407784C2 (ru) 2003-12-17 2010-12-27 Н.В. Нютрисиа Пробиотический штамм lactobacillus casei, продуцирующий молочную кислоту, применение штамма для приготовления питательной композиции для лечения или профилактики легочной дисфункции, питательная композиция и способ ее получения, лекарственное средство для лечения или профилактики хронической обструктивной болезни легких у субъекта и применение штамма для приготовления лекарственного средства, контейнер
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1642570A1 (fr) 2004-10-04 2006-04-05 L'oreal Composition cosmétique et/ou dermatologique pour peaux sensibles
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
MX2007004135A (es) * 2004-10-04 2007-06-15 Oreal Composicion cosmetica y/o dermatologica para pieles sensibles.
EP1731137A1 (fr) * 2005-06-08 2006-12-13 Nestec S.A. Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
EP2264164A1 (en) 2005-05-11 2010-12-22 Chr. Hansen A/S New antibiotic-sensitive lactic acid bacteria strains
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
JP2009067679A (ja) * 2005-12-27 2009-04-02 Univ Of Tokushima 抗ヒスタミン作用を有する医薬
US20090305996A1 (en) 2006-03-10 2009-12-10 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
WO2008058854A1 (en) * 2006-11-15 2008-05-22 Chr. Hansen A/S New tetracycline-sensitive bifidobacteria strains
WO2008071930A1 (en) 2006-12-11 2008-06-19 Danisco A/S Composition
WO2008101450A1 (de) * 2007-02-22 2008-08-28 Schrezenmeir Juergen Probiotische, gram-positive bakterien zur prophylaxe, unterdrückung oder eliminierung von allergischen reaktionen bei menschen
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2008134760A1 (en) * 2007-04-30 2008-11-06 Clinical Decision Support, Llc Arbiter system and method of computerized medical diagnosis and advice
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
RU2431663C2 (ru) * 2008-01-28 2011-10-20 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") ИММУНОБИОЛОГИЧЕСКОЕ ПРОТИВОАЛЛЕРГИЧЕСКОЕ СРЕДСТВО (ВАРИАНТЫ) И ШТАММ Lactobacillus acidophilus 100 аш ПА, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРОИЗВОДСТВА ИММУНОБИОЛОГИЧЕСКОГО ПРОТИВОАЛЛЕРГИЧЕСКОГО СРЕДСТВА
AU2009228716B2 (en) 2008-03-28 2015-01-15 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
US20110053889A1 (en) * 2008-09-02 2011-03-03 Joanne Szabo Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function
RU2393214C1 (ru) * 2009-01-29 2010-06-27 Общество с ограниченной ответственностью "ИнноПроб"(ООО"ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus nkjc, штамм lactobacillus acidophilus jch, штамм lactobacillus acidophilus kaa
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
WO2011044516A2 (en) * 2009-10-09 2011-04-14 Prothera, Inc. Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
CN102269858A (zh) 2010-06-02 2011-12-07 北京智朗芯光科技有限公司 自动聚焦系统和自动聚焦方法
MX347326B (es) * 2010-06-30 2017-04-20 L'oreal * El uso de ácido caftárico y bateria láctica en complemento alimenticio para regular la pigmentación de la piel.
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (en) 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
ES3005933T3 (en) 2011-06-20 2025-03-17 Heinz Co Brands H J Llc Probiotic compositions and methods
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX368124B (es) 2011-08-29 2019-09-19 Abbott Lab Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
EP2617296A1 (en) * 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
CN110201003A (zh) 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
ES3010649T3 (en) 2012-06-18 2025-04-04 Heinz Co Brands H J Llc Gluten-related disorders
WO2014052438A1 (en) 2012-09-25 2014-04-03 Regents Of The University Of Minnesota Methods for making and using antimicrobial peptides
MX370692B (es) 2013-05-10 2019-12-19 Heinz Co Brands H J Llc Probióticos y métodos de uso.
US20150064304A1 (en) * 2013-09-03 2015-03-05 Mario Medri Probiotic lozenge, method of making same, and uses thereof
MX379145B (es) * 2013-11-15 2025-03-11 Soc Des Produits Nestle S A Star Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesárea.
WO2015090349A1 (en) 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants
EP2886660A1 (en) * 2013-12-20 2015-06-24 Rigas Tehniska universitate A fluorescent in situ hybridization method for identification of a microorganism
CN113730442A (zh) 2014-10-31 2021-12-03 潘德勒姆治疗公司 与病症的微生物治疗和诊断有关的方法和组合物
SG11201707657UA (en) * 2015-03-18 2017-10-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of skin disorders
CA2950839C (en) * 2016-01-30 2023-09-12 Cooper Technologies Company Equipment rack and components thereof
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
AU2019306649A1 (en) 2018-07-19 2021-02-04 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
AU2019410036A1 (en) * 2018-12-21 2021-06-03 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
WO2021138599A1 (en) * 2020-01-03 2021-07-08 Forte Subsidiary, Inc. Cosmetic compositions
JP2023550962A (ja) * 2020-11-24 2023-12-06 ジョンソン アンド ジョンソン コンシューマー インコーポレイテッド アトピー性疾患を予防、遅延、又は改善する方法
CN119790135A (zh) 2022-08-25 2025-04-08 科·汉森有限公司 具有改善的稳定性的双歧杆菌菌株

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5246591A (en) * 1990-07-13 1993-09-21 Pact, Incorporated Separation of metal ions on an anion exchange resin by chromatographic elution
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
GB9808579D0 (en) * 1998-04-22 1998-06-24 Novartis Nutrition Ag Improvements in or relating to organic compounds
JP4010062B2 (ja) * 1998-09-02 2007-11-21 医療法人社団青藍会 アトピー性皮膚炎を防ぐ保健食品
JP2000086524A (ja) 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases

Also Published As

Publication number Publication date
DE01951716T1 (de) 2005-06-23
AU7257201A (en) 2002-01-02
DE60139554D1 (de) 2009-09-24
FI110668B (fi) 2003-03-14
PT2201955T (pt) 2019-11-25
US20060013806A1 (en) 2006-01-19
EP2206507B1 (en) 2019-03-13
EP1296694B1 (en) 2009-08-12
ES2754797T3 (es) 2020-04-20
EP2206507A1 (en) 2010-07-14
EP1296694A1 (en) 2003-04-02
US7988960B2 (en) 2011-08-02
US20030180272A1 (en) 2003-09-25
PT1296694E (pt) 2009-10-28
AU784921B2 (en) 2006-07-27
EP2201955B1 (en) 2019-08-14
WO2001097822A1 (en) 2001-12-27
ATE439138T1 (de) 2009-08-15
EP2201955A1 (en) 2010-06-30
ES2721848T3 (es) 2019-08-05
FI20001460L (fi) 2001-12-21
US7112322B2 (en) 2006-09-26
ES2329549T3 (es) 2009-11-27

Similar Documents

Publication Publication Date Title
FI20001460A0 (fi) Probiootit atooppisten sairauksien primaariseen ehkäisyyn
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
DE69930944D1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
EP1634600A4 (en) ANTIALLERGIC COMPOSITION
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
DE60226254D1 (de) Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
TW200612971A (en) Method for preventing or treating respiratory infections and acute otitis media in infants
ATE485827T1 (de) Ernährungszusammensetzung
IL156490A0 (en) Probiotic compounds derived from lactobacillus casei strain ke01
EP1555028A4 (en) ANTIALLERGIC AGENT, ITS USE TO REDUCE ALLERGIES AND METHOD FOR REDUCING ALLERGIES
HK1049115A1 (zh) 治療過敏性失調的成分和方法
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
MXPA04005002A (es) Bacterias lacticas y su uso en el tratamiento y la prevencion del cancer.
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
AL-Saeedi et al. Bacteriocin from Streptococcus salivarius optimized statistically by response surface methodology active against different clinical oral pathogenic Streptococci
Agarwal et al. Probiotics and oral health: a review

Legal Events

Date Code Title Description
RF Appeal filed
PC Transfer of assignment of patent

Owner name: NESTEC S.A.

Free format text: NESTEC S.A.

FCK Appeal rejected